𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of a transdiagnostic group treatment for anxiety on secondary depression

✍ Scribed by Peter J. Norton; Sarah A. Hayes; Debra A. Hope


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
111 KB
Volume
20
Category
Article
ISSN
1091-4269

No coin nor oath required. For personal study only.

✦ Synopsis


Researchers have recently explored transdiagnostic anxiety treatments based on models of anxiety emphasizing a single common pathway across diagnostic categories. Results from a previous study [Norton and Hope, in press] indicated that a transdiagnostic approach was effective for both targeted and untargeted anxiety disorders. Consistent with the tripartite model, the transdiagnostic treatment should also influence symptoms of a broader pathology such as negative affectivity. This follow-up to Norton and Hope found significant decreases in depressed mood for clients undergoing transdiagnostic treatment for anxiety when compared to wait-list control participants. Although not statistically established, severity of depressive diagnoses seemed to generally decrease across treatment, whereas no change in severity occurred for those not receiving treatment. Depression and Anxiety 20:198-202, 2004. & 2005 Wiley-Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Use of paroxetine for the treatment of d
✍ Michel Bourin πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 67 KB πŸ‘ 2 views

## Abstract Paroxetine is a potent selective serotonin reuptake inhibitor (SSRI) with indications for the treatment of depression, obsessive– compulsive disorder, panic disorder and social phobia. It is also used in the treatment of generalized anxiety disorder, post‐traumatic stress disorder, prem